Literature DB >> 26980929

Investigation of Cardiac Complications and their Incidence in Patients with Ankylosing Spondylitis.

Mohsen Soroush1, Mahmood Mominzadeh1, Younes Ghelich2, Soosan Soroosh1, Morteza Aghajanpoor Pasha3.   

Abstract

INTRODUCTION: Ankylosing Spondylitis (AS) is a chronic inflammatory disease with unknown etiology which involves the sacroiliac and axial joints, but can also cause peripheral conflicts. It also comprises non-joint symptoms such as acute anterior uveitis, cardiac conduction defects, upper lobe pulmonary fibrosis, neurological involvement and renal amyloidosis.
MATERIAL AND METHODS: This study was a cross-sectional descriptive and analytical survey. In this study, 50 patients with AS were examined according to the New York Criteria in Army 501 Hospital in Tehran. Physical examinations, laboratory testing and HLA-B27, as well as X-ray of the spine and sacroiliac joint were taken from all subjects and involvement grading was identified. The control group consisted of 40 healthy people with no evidence of disease. The people resembled the study group in terms of age, sex, smoking, presence of high blood pressure, history of ischemic heart disease and also diabetes.
RESULTS: The mean age of patients in control and study group was 33.97 and 33.65 years, respectively. 37 (92.5%) patients in the control group and 46 in study group (92%) were male. The mean duration of cardiac involvement in patients was 8.6 years with SD=6.26. In AS group, 48 (96%) patients suffered from back pain, 43 from enteritis, 100% from Ankylosing Spondylitis, one from unilateral involvement, 22(44%) from peripheral arthritis and 27 (54%) from HLA-B27.
CONCLUSION: In total, Average heart involvement in the control group and AS group was 13.25 with SD=7.64 and 16.2 with SA=8.54, respectively, indicating no significant difference. In sum, based on the results obtained in this study, some types of heart involvements, such as mitral valve regurgitation and Mitral Valve Prolapse in AS patients are more prevalent than in the normal population.

Entities:  

Keywords:  Ankylosing Spondylitis; Arthritis; Cardiac involvement; Mitral valve

Mesh:

Year:  2016        PMID: 26980929      PMCID: PMC4779348          DOI: 10.5455/medarh.2016.70.35-38

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


1. INTRODUCTION

Ankylosing Spondylitis is an inflammatory disease with unknown etiology causing chronic inflammation of the joints and surrounding structures of the spine. The inflammation may lead to focal bone erosions and new bone formation. In this condition, there is a possibility of peripheral joint involvement and also, the development of inflammatory lesions in Non-articular organs such as eyes, heart, lungs, kidneys and digestive system (1, 2) . The disease appears at young ages and predisposing family factors affect it and also there is a strong association with MHC genetic polymorphism (HLA-B27). The New York Criteria is used to diagnose Ankylosing Spondylitis in patients, so the same criteria has been used to classify Ankylosing Spondylitis in patients (3, 4). There is a significant correlation between the AS and histocompatibility antigens. Ankylosing Spondylitis disease affects men more than women (3:1) and the age of onset is typically from early adolescence to age 35 and peak at age 28 (5, 6). Family history can be seen in 20-15% of cases and the risk for HLA-B27 positive is almost 20% (7). No specific reason has been found so far and no environmental factor such as bacterial pathogens has been defined for it. However, Klebsiella pneumonia has 6 amino acids similar to HLA-B27 and it seems that molecular mimicry is effective in its role in causing the disease (8-13). It should be noted that pathogenesis is not fully understood for AS, but it is almost certainly immune mediated (14-16). Clinical symptoms of the disease are chronic back pain and stiffness which are typical early signs and start gradually. The pain in Ankylosing Spondylitis has inflammatory nature, so that appears in the morning and resting time and improves followed by activity (2, 14). Enteritis, especially plantar tendon problem, may exist which will lead to heel pain. The first unusual symptom in clinical examinations in Ankylosing Spondylitis is usually tenderness in sacroiliac joint or pain in the same area with hip hyperextension. Findings from long-term observations showed that in the long term, cases such as flattening the normal lumbar lordosis curve and limiting the movements in all lumbar spine planes are visible. When the disease progresses towards thoracic spine, chest expansion is limited (under 2.5 cm), resulting from cost vertebral joint fusion, and considering as a specific sign for AS, especially in young people (2, 14). In addition to detailed clinical symptoms mentioned, some symptoms can be also seen in other organs and out of joint, such organs as eyes, lungs, kidneys, digestive system, nervous system and heart (2, 14, 17). Aortic insufficiency and variable degrees of atrioventricular block or branch block can be seen in approximately 5% of patients with a long period of illness. Less commonly, mitral insufficiency can be associated with aortic disease and almost all of the patients are HLA-B27 positive (18, 19). Valve involvement is histopathologically due to infiltration and accumulation of plasma cells and lymphocytes around the Vasa Vasorum, causing their lumen to be narrowed and the changes dilate and thicken the aortic root wall and shorten and thicken the aortic valve leaflets. Extension of inflammatory process and secondary fibrosis towards cardiac conduction system, namely, AV node and conduction branch proximal part, is the reason for conduction block (20-22). In this study, the overall objectives are to investigate the frequency and type of cardiac involvement in patients referred to Army 501 Hospital, Tehran, and more specifically, frequency of cardiac involvement and complications in two groups of AS patients and healthy individuals, and finally comparing them and also examining the frequency of HLA-B27 and joint involvement in these patients.

2. MATERIALS AND METHODS

This study was a cross-sectional, descriptive-analytical survey, in which 50 patients with Ankylosing Spondylitis referred to Army 501 Hospital, Tehran, in 2001 - 2008 were compared with 40 healthy subjects as controls. This was a case-control study in which people with AS had been confirmed according to the New York Criteria. All patients, in addition to clinical examinations, underwent X-ray of the spine and sacroiliac joint. Also, all patients were referred to cardiologist to perform physical examination, electrocardiography and echocardiography during their visits. Control group was selected among healthy people having no signs of disease. The people were matched with the study group according to age, sex, smoking, high blood pressure, history of ischemic heart disease and also diabetes mellitus and finally referred to a cardiologist for electrocardiography and echocardiography. After collecting the information obtained and recording them, variables were analyzed using the software SPSS (Ver 15).

3. RESULTS

From total amount of patients in our sample, 50 AS patients were included in this study, 46 (92%) males and the remaining females. The control group consisted of 37 (92.5%) males and 3 (7.5%) females. The mean duration of disease in AS patients was 8.6 years, with 1 year minimum to 26 years maximum disease duration. The mean age of patients was reported 33.65 (SD=10.23) with age range of 20 to 63 years and age density between 20 to 40 years. In the control group, the mean age was 34 years (SD: 10.73) with minimum and maximum age of 20 and 63 years, respectively. Investigation of the frequency of HLA-B27 in patient group showed that 27 patients were HLA-B27 positive and 23 patients negative. Furthermore, the frequency of peripheral arthritis in the group indicated that 22 (44%) patients had peripheral arthritis and 28 (56%) were free of this complication. All AS patients had sacroiliac joint involvement, 49 (98%) bilateral and only 1 (2%) unilateral involvement. Based on back pain distribution, 48 (96%) patients had back pain and 2 (4%) were free of it. The frequency of different types of heart failure were studied, including aortic stenosis, aortic regurgitation, mitral stenosis, mitral regurgitation, mitral valve prolapse, tricuspid valve stenosis, tricuspid valve regurgitation, pulmonary valve stenosis and pulmonary valve regurgitation, that the results can be seen in Table 1.
Table 1

The frequency of different heart failure in AS patient and comparison with control group

The frequency of different heart failure in AS patient and comparison with control group ECG changes in both groups of AS patients and controls were studied. In patient group, 46 (98%) subjects had no changes and only 1 (2%) subject showed ECG changes in favor of RBBB who was HLA-B27 negative. In control group, 36 (90%) subjects unchanged and 4 (10%) had ECG change. The changes were RBBB in 1, PVC in 2 and T-invert in 1 (Figure 1).
Figure 1

ECG changes in AS patients and controls

ECG changes in AS patients and controls Finally, since independent qualitative variable had two status (healthy group and AS patient group) and dependent variable was quantitative, T-test was used. Consequently, the average of this variable in AS patients and control group was 16.2±8.56 and 13.25±7.64. Because the significance level is P = 0.09 (>0.05), the main hypothesis is rejected, suggesting that being AS patient or healthy has no influence on cardiac involvement.

4. DISCUSSION

Ankylosing Spondylitis (AS) is a chronic inflammatory disease characterized by inflammation of the spinal cord and peripheral skeleton that can lead to local bone erosions or osteoporosis at the primary site. AS pathogenesis has not been fully recognized, but it is almost certainly immunity mediated. No laboratory test is diagnostic for AS. ESR and CRP are often high in most patients, but not always (23). Mild anemia may also be present. In severe cases, alkaline phosphatase level may also be high. On the other hand, in addition to peripheral joints and spine, other organs are also involved such as digestive system, lungs, eyes, kidneys, nervous system and heart. According to a recent study of AS patients, their cardiac involvement is divided into constructive involvement of heart itself including valves and vessels and cardiac conduction system. Valve involvements are as aortic or mitral insufficiency and conduction disorders as atrioventricular blocks or branch block that can be seen in approximately 5% of patients with long-term illness. Valve involvement is histopathologically due to infiltration of inflammatory cells, especially plasma cells and lymphocytes. Also, conduction disorders are led by inflammatory process and secondary fibrosis in conduction system. It is worth mentioning that cardiac involvement may be the first symptom in clinical examinations in AS patient and the patient refers with symptoms like pectoral angina, dyspnea, fatigue, syncope, followed by Stokes - Adams attack (2, 14, 19). According to the results reported in detail in the results (table and graph), mitral valve regurgitation and its prolapse are the only findings with higher prevalence in AS patient than healthy controls and it is not true in other cases. It also seems that there is no logical relationship between AS diseases and cardiac complications due to the low number of subjects studied, and the incidence of cardiac complications had no significant difference in the patient and control groups (p=0.09). Some studies have been already done on the relationship between heart failure and AS disease. 88 patients with AS underwent a physical examination, electrocardiography and echocardiography in Turkey. In this study, 5 out of 88 patients (5.7%) had some evidence of MVP, 6 (6.8%) mitral valve thickening without prolapse, 5 (5.7%) sever mitral regurgitation and 2 (2.3%) moderate aortic regurgitation that was lower than data obtained in the present study (24). Also, in another study conducted on 100 patients with AS in Bulgaria, statistical result of valvular disorders and conduction disorders was higher and lower than the present study, respectively (25). In one of the studies conducted in America, 44 patients with AS and 25 healthy subjects underwent clinical assessments and echocardiography. 82% of patients had aortic valve or root disease and in contrast, 27% of the control group had the same failure and valve regurgitation was observed in 50% of patients, that the data obtained in the control and patient groups was higher than the present study (26). In a study conducted by Brewerton et al., 5 out of 28 patients with AS suffered from more dilated left ventricle with poor muscle strength and early abnormalities in left ventricular diastolic were seen in echocardiography in 16 out of 28 patients with AS, who had been identified without cardiopulmonary symptoms and heart anomalies (27).

5. CONCLUSIONS

In conclusion, in total, according to data obtained in this study, it is suggested that the frequency of cardiac involvement in patients with AS doesn’t differ with general population. But some of them, such as mitral valve regurgitation and mitral valve prolapse, had higher prevalence in AS patients than normal population in our study. It should be noted that minimal involvement of aortic valve observed in this study can be caused by a short period of illness, so that in other studies, the mean duration was 17-16 years, but in our study it was 8.6±6.26 years.
  26 in total

1.  Bone mineral density in mild and advanced ankylosing spondylitis.

Authors:  Kazim Capaci; Simin Hepguler; Mehmet Argin; Isil Tas
Journal:  Yonsei Med J       Date:  2003-06-30       Impact factor: 2.759

2.  Nervous system involvement in ankylosing spondylitis.

Authors:  D J Thomas; M J Kendall; A G Whitfield
Journal:  Br Med J       Date:  1974-01-26

3.  Ankylosing spondylitis associated with pulmonary arterial hypertension.

Authors:  Yao-Min Hung; Chin-Chang Cheng; Shue-Ren Wann; Shoa-Lin Lin
Journal:  Intern Med       Date:  2015       Impact factor: 1.271

Review 4.  Ankylosing spondylitis: an overview.

Authors:  J Sieper; J Braun; M Rudwaleit; A Boonen; A Zink
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

5.  Impact of sex on inheritance of ankylosing spondylitis: a cohort study.

Authors:  A Calin; S Brophy; D Blake
Journal:  Lancet       Date:  1999-11-13       Impact factor: 79.321

6.  C-reactive protein, ESR, and klebsiella in ankylosing spondylitis.

Authors:  P Cowling; R Ebringer; D Cawdell; M Ishii; A Ebringer
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

7.  The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study.

Authors:  D A Brewerton; D G Gibson; D H Goddard; T J Jones; R B Moore; C T Pease; P A Revell; L M Shapiro; K V Swettenham
Journal:  Lancet       Date:  1987-05-02       Impact factor: 79.321

8.  Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan.

Authors:  K Mikecz; T T Glant; A R Poole
Journal:  Arthritis Rheum       Date:  1987-03

9.  IgA antibodies to Klebsiella pneumoniae in ankylosing spondylitis.

Authors:  A K Trull; R Ebringer; G S Panayi; D Colthorpe; D C James; A Ebringer
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

Review 10.  Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

Authors:  Juergen Braun; Joachim Sieper
Journal:  Arthritis Res       Date:  2002-08-06
View more
  7 in total

1.  Left ventricular non-compaction in a patient with ankylosing.

Authors:  Mehrnoush Toufan; Leili Pourafkari; Nader D Nader
Journal:  J Cardiovasc Thorac Res       Date:  2016-12-30

2.  Ankylosing Spondylitis and Risk of Cardiac Arrhythmia and Conduction Disorders: A Systematic Review and Meta-analysis.

Authors:  Negar Morovatdar; Gerald F Watts; Yones Bondarsahebi; Fatemeh Goldani; Elham Rahmanipour; Ramin Rezaee; Amirhossein Sahebkar
Journal:  Curr Cardiol Rev       Date:  2021

3.  Echocardiographic and Electrocardiographic Findings in Patients with Ankylosing Spondylitis without Cardiovascular Risk Factors.

Authors:  Simin Almasi; Behzad Farahani; Niloufar Samiei; Yousef Rezaei; Habib Mahmoodi; Mostafa Qorbani
Journal:  J Tehran Heart Cent       Date:  2020-04

4.  Mitral valve disease in ankylosing spondylitis: an autoimmune disease manifestation? A case report.

Authors:  Sulayman El Mathari; Allard van der Wal; Hennie Raterman; Jolanda Kluin
Journal:  Eur Heart J Case Rep       Date:  2022-08-01

5.  A case of ankylosing spondylitis with concurrent Takayasu arteritis.

Authors:  Masakazu Matsushita; Shigeto Kobayashi; Kurisu Tada; Eri Hayashi; Ken Yamaji; Atsushi Amano; Naoto Tamura
Journal:  J Int Med Res       Date:  2018-04-24       Impact factor: 1.671

6.  Heart Involvement in a Moroccan Population with Spondyloarthritis: A Cross-sectional Study.

Authors:  Jalila Eddarami; Hamida Azzouzi; Linda Ichchou
Journal:  J Saudi Heart Assoc       Date:  2021-07-08

7.  Increased risk of valvular heart disease in patients with ankylosing spondylitis: a nationwide population-based longitudinal cohort study.

Authors:  Wun-Zhih Siao; Chin-Hsiu Liu; Yu-Hsun Wang; James Cheng-Chung Wei; Gwo-Ping Jong
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-06-18       Impact factor: 5.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.